Meeting News

Gene mutations may improve prognosis models for certain patients with leukemia subtype

February 20, 2018
ATLANTA — Contrary to previous research, treatment with hypomethylating agents seem to only partially negate the poor prognosis of certain…
Meeting News

CAR T cells appear effective in leukemia subtype

February 20, 2018
ATLANTA — Chimeric antigen receptor T cells have been at the forefront of immunotherapy for the treatment of B-cell malignancies, according to…
Meeting News

Addition of IDH inhibitors to standard chemotherapy improves outcomes in leukemia subtype

February 16, 2018
ATLANTA — Ivosidenib or enasidenib used in combination with standard induction therapy provided encouraging response rates and appeared well…
Meeting News

Azacitidine possibly more than a palliative option for leukemia subtype

January 30, 2018
ATLANTA — The use of azacitidine in an older patient population that tends to experience poor outcomes with intensive chemotherapy appeared to…
Meeting News

Ivosidenib appears safe, effective in leukemia subtype

January 29, 2018
ATLANTA — Ivosidenib monotherapy was well tolerated in patients with acute myeloid leukemia and an IDH1 mutation, according to results of a…
Meeting News

Ponatinib ‘promising’ for leukemia subtype, concerns remain

January 28, 2018
ATLANTA — The GIMEMA LAL1811 trial demonstrated some “pretty promising” results for the use of ponatinib with steroids in elderly…
Meeting News

Detecting minimal residual disease may act as ‘surrogate endpoint’ for drug approvals

January 9, 2018
ATLANTA — Research is ramping up to find the best way to detect minimal residual disease in patients with acute myeloid leukemia, according to…
Meeting News

Dasatinib, chemotherapy combination appears effective in pediatric patients with leukemia subtype

January 5, 2018
ATLANTA — The addition of dasatinib to imatinib plus chemotherapy conferred survival benefit and appeared safe in pediatric patients with…
Meeting News

Reduced transfusion frequency may increase hospice referral in leukemia patients

January 3, 2018
ATLANTA — Patients with leukemia are less likely to be referred to hospice toward the end of life than patients with solid tumors, but…
Meeting NewsPerspective

Most adolescents, young adults with leukemia subtype treated with therapies meant for adults

December 15, 2017
ATLANTA — The number of adolescents and young adults with acute lymphoblastic leukemia treated with pediatric-inspired chemotherapy regimens…